Skip to main content
MLEC logo

MLEC

Moolec Science SA
$7.74 +0.05 (+0.62%) At close · Jul 8
Market Cap
$5.32M
Shares
726,118

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$7.74 Open$7.55 Day$7.00–7.74 52W$3.08–89.96 Avg vol 30d23K Short int21K · 2.9% float · 1.0d Short vol64% Last earningsJun 30, 2024 DataMar 2021–Jul 2026
Equibles Rating blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 16.9 · calm Equity put/call 0.86
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −9%
below
Price vs 50-day avg −4%
below
RSI (14) 50
neutral
MACD trend Positive
52-week position 5%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +8%
trailing
6-month return +58%
trailing
YTD return +102%
this year
Relative strength +50%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $8 › 200d $8 — 200d above 50d
Institutional flow Accumulating
+200% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.86% of float · ▲ +128.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
3 holders — 13F breadth
Squeeze score 42
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 206%
annualized · 1-yr
Max drawdown −96%
past year
ATR 9.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next
FQ1-27 quarter ends
~Sep 30, 2026 Est

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−9% Bearish
Price vs 50-day avg
−4% Neutral
RSI (14)
50 Neutral
MACD trend
Positive Bullish
52-week position
5% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $8 › 200d $8 — 200d above 50d
Institutional flow Accumulating
+200% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.86% of float · ▲ +128.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
3 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $3 Now $8 · 5% 52-wk high $90
vs 200-day avg -9% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MLEC
Moolec Science SA
this stock
$5.32M +102.3% 2.9%
ONC
BeOne Medicines Ltd.
$437.67B -0.6% +22179.2% 890.7 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
$126.01B +9.9% +46.2% 29.5 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
$70.03B -14.0% +20.8% 16.3 3.2%
ARGX
Argenx SE
$56.84B +8.8% 2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
3
% held
2.3%
Net QoQ
+16.6K sh
Top holder
HRT FINANCIAL LP
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
20.7K
Days to cover
1.0d
Change
+11.7K sh
View
Short Volume
Short vol %
64%
As of
Jul 9, 2026
Short Total
View
Fails to Deliver
FTD shares
194
Value
$1.4K
As of
Jun 12, 2026
View
Off-Exchange
Off-exchange %
30.2%
Week of
May 4, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Jun 2, 2026
This year
11
View
Earnings & Events
Earnings Calls
Last call
Jun 30, 2024
View

Performance

5D 20D 120D MTD YTD
MLEC +3.6% +8.4% +57.6% +3.6% +102.3%
SPY -0.2% +0.8% +7.4% -0.2% +9.3%
vs SPY +3.8% +7.5% +50.2% +3.8% +93.0%
Key facts CIK 1937737 CUSIP G6223S125 Visit website